UNITED GUARDIAN Business Summary

United-Guardian, Inc. (UG) operates as a specialty chemical and pharmaceutical manufacturer, generating revenue through the development and B2B sale of proprietary hydrogel formulations and niche medical products. The company’s business is organized into four primary segments: Cosmetic Ingredients, centered on the trademarked Lubrajel line of multifunctional hydrogels; Pharmaceuticals, featuring the FDA-approved urological solution Renacidin; Medical Lubricants, used for surgical and diagnostic device applications; and Sexual Wellness, a growth-focused category utilizing its Natrajel technology. UGI leverages a high-margin, low-volume model, relying on a global distribution network—most notably a long-standing partnership with Ashland Inc.—to reach international markets. In a competitive landscape dominated by diversified chemical giants such as Ashland Global, BASF, and Croda International, United-Guardian maintains a defensible niche by focusing on high-purity, patented formulations that offer superior sensory and lubricious properties over commodity alternatives. The leadership team is currently headed by Donna Vigilante, who serves as President and Chief Executive Officer; she brings over 20 years of internal experience and a background in biochemistry from Stony Brook University to the role. Financial operations are managed by Andrea J. Young, who serves as Chief Financial Officer, Treasurer, and Secretary, overseeing the firm’s conservative fiscal strategy and its 31-year streak of consecutive dividend payments as of early 2026. The company was founded in 1942 by the late Alfred R. Globus, and his legacy continues through Chairman Kenneth H. Globus, the former CEO and current controlling shareholder who provides strategic oversight alongside a board of seasoned industry veterans including Arthur M. Dresner and Lawrence F. Maietta. Institutional stability is further supported by significant holdings from investors such as Gabelli Funds and Renaissance Technologies, reflecting the company's status as a specialized, family-influenced public entity with a lean executive structure.